Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-09-20
2008-10-14
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S013800, C514S014800, C514S018700, C530S300000, C530S324000, C530S326000, C530S327000, C530S330000
Reexamination Certificate
active
07435718
ABSTRACT:
In accordance with various aspects of the invention, CXCR4 antagonists may be used to treat hematopoietic cells, such as progenitor or stem cells, to promote the rate of cellular multiplication, self-renewal, proliferation or expansion. CXCR4 antagonists may be used therapeutically to stimulate hematopoietic stem/progenitor cell multiplication/self-renewal.
REFERENCES:
patent: 2530369 (1950-11-01), Simons
patent: 2760992 (1956-08-01), Schoeffel et al.
patent: 4554101 (1985-11-01), Hopp
patent: 4868116 (1989-09-01), Morgan et al.
patent: 4980286 (1990-12-01), Morgan et al.
patent: 5082670 (1992-01-01), Gage et al.
patent: 5166320 (1992-11-01), Wu et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5401651 (1995-03-01), Walz
patent: 5563048 (1996-10-01), Honjo et al.
patent: 5756084 (1998-05-01), Honjo et al.
patent: 5807744 (1998-09-01), Berneman et al.
patent: 5856301 (1999-01-01), Craig et al.
patent: 5871723 (1999-02-01), Strieter et al.
patent: 5919776 (1999-07-01), Hagmann et al.
patent: 5962462 (1999-10-01), Mills et al.
patent: 5990163 (1999-11-01), Evans et al.
patent: 6013644 (2000-01-01), Mills et al.
patent: 6022848 (2000-02-01), Kozlov et al.
patent: 6046185 (2000-04-01), Burgoyne et al.
patent: 6124319 (2000-09-01), MacCoss et al.
patent: 6132987 (2000-10-01), Charo et al.
patent: 6133319 (2000-10-01), Widdowson
patent: 6136827 (2000-10-01), Caldwell et al.
patent: 6140349 (2000-10-01), Caldwell et al.
patent: 6166037 (2000-12-01), Budhu et al.
patent: 6204294 (2001-03-01), Bryan et al.
patent: 6356887 (2002-03-01), Berenson et al.
patent: 6515001 (2003-02-01), Saxena et al.
patent: 6613742 (2003-09-01), Huang et al.
patent: 6693134 (2004-02-01), Saxena et al.
patent: 6875738 (2005-04-01), Clarke Lewis et al.
patent: 6946445 (2005-09-01), Clarke Lewis et al.
patent: 2002/0156034 (2002-10-01), Tudan et al.
patent: 2002/0165123 (2002-11-01), Tudan et al.
patent: 2003/0004136 (2003-01-01), Saxena et al.
patent: 2003/0045550 (2003-03-01), Saxena et al.
patent: 2003/0092674 (2003-05-01), Saxena et al.
patent: 2003/0125380 (2003-07-01), Saxena et al.
patent: 2003/0148940 (2003-08-01), Tudan et al.
patent: 2002/0202963 (2003-10-01), Crystal et al.
patent: 2005/0059584 (2005-03-01), Merzouk et al.
patent: 2005/0164935 (2005-07-01), Clarke Lewis et al.
patent: 2005/0265969 (2005-12-01), Clarke Lewis et al.
patent: 2006/0014682 (2006-01-01), Clarke Lewis et al.
patent: WO 89/02468 (1989-03-01), None
patent: WO 89/05345 (1989-06-01), None
patent: WO 89/07136 (1989-08-01), None
patent: WO 90/06757 (1990-06-01), None
patent: WO 91/04274 (1991-04-01), None
patent: WO 92/07573 (1992-05-01), None
patent: WO 93/10234 (1993-05-01), None
patent: WO 93/13206 (1993-07-01), None
patent: WO 95/05452 (1995-02-01), None
patent: WO 95/09236 (1995-04-01), None
patent: WO 96/40772 (1996-12-01), None
patent: WO 97/28257 (1997-08-01), None
patent: WO 97/28258 (1997-08-01), None
patent: WO 98/04684 (1998-02-01), None
patent: WO 98/04698 (1998-02-01), None
patent: WO 98/09642 (1998-03-01), None
patent: WO 98/51705 (1998-11-01), None
patent: WO 99/47158 (1999-09-01), None
patent: WO 00/09152 (2000-02-01), None
patent: WO 00/66112 (2000-09-01), None
patent: WO 01/76615 (2001-10-01), None
patent: WO 01/85196 (2001-11-01), None
patent: WO 2004/024088 (2004-03-01), None
J. Rudinger. In: Peptide Hormones, JA Parsons, Ed. (1976) 1-7.
S. Nema et al. PDA J. Pharm. Sci. Tech. (1997) 51, pp. 166-171.
U.S. Appl. No. 10/932,208, filed Aug. 31, 2004, Merzouk et al.
U.S. Appl. No. 10/243,795, filed Sep. 13, 2002, Merzouk et al.
Acsadi, G., et al.,Nature352:815-818, (1991).
Aiuti, A., et al.,J. Exp. Med.185(1):111-120, (1997).
Aiuti, A., et al.,Eur. J. Immunol.29:1823-1831, (1999).
Alkhatib, G. et al.,Science272:1955-1958, (1996).
Allen, M. et al.,J. Biomolecular Screening5(2):63-69, (2000).
Alleva, D., et al.,J. Immunol.161(12):6878-6884, (1998).
Anderlini, P., et al.,Blood90(3), 903-908, (1997).
Anderson, W., et al.,Science288:627-629, (2000).
Arenzana-Selsdedos, F., et al.,Nature383:400, (1996).
Armentano, D., et al.,Proc. Nat'l. Acad. Sci.87:6141-6145, (1990).
Ausubel, et al.,Current Protocols in Mol. Biol. Supp.36:9.10.1-9.14.6, (1995).
Avenarius, H., et al.,Inter. J. Hematology58:189-196, (1993).
Baggiolini, M.,Nature392:565-568, (1998).
Baird, A., et al.,Current Opinion in Immunology11:157-166, (1999).
Balasa, B., et al.,J. Exp. Med.186:385-391, (1997).
Baldari, et al.,The EMBO J.6(1):229-234, (1987).
Barbier, J., et al.,J. Med. Chem.40(9):1373-1380, (1997).
Barbier, J., et al.,Biochemistry39(47):14522-14530, (2000).
Banerji, et al.,Cell33:729-740, (1983).
Barnes, D., et al.,J. Clin. Invest.101(12):2910-2919, (1998).
Belperio, et al.,J. Leukoc. Biol.68:1-8, (2000).
Benoist, et al.,Nature290:304-310, (1981).
Berkner, K.,Biotechinques6(7):616-628, (1988).
van Beuschem, V., et al.,Proc. Nat'l. Acad. Sci89:7640-7644, (1992).
Blease, K., et al.,J. Immunol.165:1564-1572, (2000).
Bleul, C., et al.,J. Exp. Med.184:1101-1109, (1996).
Bleul, C., et al.,Nature382:829-832, (1996).
Bollon, et al.,J. of Clinical Hemotology and Oncology10:39-48, (1980).
Bork, et al.,Trends in Genetics12(10):425-427, (1996).
Bork, A.,Genome Res.10:398-400, (2000).
Botstein, et al., “Making Mutations in Vitro and Putting them Back Into Yeast”, Dept of Biol. Massachussetts Institute of Technology, 265-274, (1982).
Brandt, J., et al.,J. Clin Invest.86:932-941, (1990).
Brandt, J., et al.,Blood79(3):634-641, (1992).
Brandt, J., et al.,J. Clin. Invest.82:1017-1027, (1998).
Brenner, S.E.,Trends in Genetics15(4):132-133, (1999).
Broach, J.R.,The Molecular Biology of the Yeast Saccharomyces, 445-470, (1981).
Broach, J.R.,Cell28:203-204, (1982).
Buckley, C., et al.,J. Immunol.165:3423-3429, (2000).
Burt, R.,Stem Cells17(6):366-372, (1999).
Buser, et al.,Methods in Molecular Biology138:143-148, (2000).
Calame, et al.,Advances in Immunology43:236-275, (1988).
Campbell, J., et al.,Science279:381-383, (1998).
Camper, et al.,Genes&Development 3, 537-546, (1989).
Carr, M., et al.,Proc. Nat'l. Acad. Sci.91:3652-3656, (1994).
Cashman, J., et al.,Blood94(11):3722-3729, (1999).
Cavazzano-Calvo, M., et al.,Science288:669-672, (2000).
Cenatiempo, Y.,Biochimie68:505-515, (1986).
Charo, I., et al.,Proc. Natl. Acad. Sci.91:2752-2756, (1994).
Choe, H., et al.,Cell85:1135-1148, (1996).
Chowdury, J., et al.,Science254:1802-1805, (1991).
Clapp, W., et al.,Blood78(4):1132-1139, (1991).
Clark-Lewis, I., et al.,J. Biol. Chem.269(23):16075-16081, (1994).
Cocchi, F., et al.,Science270:1811-1815, (1995).
Colosimo, et al.,BioTechniques29:314-331, (2000).
Combadiere, C., et al.,J. Biol. Chem.270:16491-16494, (1995).
Conti, J., et al.,Cancer70(11):2699-2702, (1992).
Cristiano, R., et al.,Proc. Nat'l. Acad. Sci.90:2122-2126, (1993).
Crump, M., et al.,EMBO Journal16(23):6996-7007, (1997).
Curiel, D., et al.,Proc. Nat'l. Acad. Sci.88:8850-8854, (1991).
Cushing, S., et al.,Proc. Nat'l. Acad. Sci.87:5134-5138, (1990).
Cwirla, S., et al.,Science276:1696-1699, (1997).
Dai, Y., et al.,Proc. Nat'l. Acad. Sci.89:10892-10895, (1992).
Danos, O., et al.,Proc, Nat'l. Acad. Sci.85:6460-6464, (1988).
Daugherty, et al.,Chemokine Protocols138:129-148, (2000).
Daugherty, et al.,Methods in Molecular Biology138:129-134, (2000).
Demirer, T., et al.,Stem Cells14:106-116, (1996).
DeNardo, et al.,Cancer94:1275-1286, (2002).
Deng, H., et al.,Nature381:661-666, (1996).
Dhib-Jalbut, S., et al.,Journal of Interferon and Cytokine Research16:195-200, (1996).
Di Salvo, J., et al.,Eur. J. Pharm.409:143-154, (2000).
Doerks, et al.,Trends in Genetics14(6):248-250, (1998).
Doranz, B., et al.,Cell85:1149-1158, (1996).
Dragic, T., et al.,Nature381:667-673, (1996).
Dufour, J.H., et al.,The Journal of Immunology167(7077-7083):3195-3204, (2001).
Dunican, A., et al.,Shock13(3):244-250, (2000).
Durig, J., et al.,Leukemia14:1652-1660, (2000).
Eck et al., Goodman & Gilman's The Phrmacological Basis of Therapeutics, 9thEdition, Chapter 5, McGraw-Hill, NY (1996).
Edlund, et al.,Science230:912-916, (1985).
Eglitis, M., et al.,Science320:1395-1
Arab Lakhdar
Cashman Johanne
Clark-Lewis, legal representative Michael
Eaves Connie J.
Merzouk Ahmed
Boyer Brian S.
Chemokine Therapeutics Corp.
Kosar Andrew D
The University of British Columbia
TIPS Group
LandOfFree
CXCR4 antagonist treatment of hematopoietic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CXCR4 antagonist treatment of hematopoietic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CXCR4 antagonist treatment of hematopoietic cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3993621